12:34 PM EDT, 11/01/2024 (MT Newswires) -- CNS Pharmaceuticals ( CNSP ) said Friday that a Nasdaq hearings panel has given it more time regain compliance with the exchange's minimum bid price requirement.
The company said it was granted until March 11, 2025 to regain compliance with the listing rule.
CNS shares were 1.3% higher in recent trading.